Briviact (in Italy: Nubriveo) - direct healthcare professional communication (DHPC)

Brivaracetam

Opis

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokumenti

Direct healthcare professional communication (DHPC): Briviact® (In Italy: Nubriveo®) (brivaracetam 10Mg/ml) Oral solution: Bottles with narrow neck diameter

Key facts

• Medicine name:
  Briviact (in Italy: Nubriveo)
• Active substance:
  Brivaracetam
• Therapeutic area (MeSH):
  Epilepsy
• Regulatory outcome:
  Maintenance
• DHPC type:
  Quality defect
• Human ATC codes:
  N03AX23
• Dissemination date:
  18/12/2021